Table 3.
Pearson's correlation coefficients for PROs and additional measures of disease activity at baseline in the treatment cohort (n = 2,788)a
| DAS28 | Functionb | Fatigue | Pain | PGA | MDGA | |
|---|---|---|---|---|---|---|
| DAS28 | 1.00 | −0.41 | 0.29 | 0.42 | 0.49 | 0.52 |
| Functionb | 1.00 | −0.48 | −0.51 | −0.53 | −0.31 | |
| Fatigue | 1.00 | 0.58 | 0.59 | 0.28 | ||
| Pain | 1.00 | 0.79 | 0.41 | |||
| PGA | 1.00 | 0.46 | ||||
| MDGA | 1.00 |
a
The negative correlations observed with function are due to a difference in the direction of the scales; higher function scores indicate improved function, whereas for the other measures lower scores indicate improved outcomes. PROs = patient‐reported outcomes; DAS28 = Disease Activity Score in 28 joints; PGA = patient global assessment; MDGA = physician global assessment.
b
As determined by the Funktionsfragebogen Hannover score.